YESWEHACK
10.3.2022 09:02:05 CET | Business Wire | Press release
Telenor Sweden has partnered with YesWeHack , Europe’s leading Bug Bounty platform, to identify potential vulnerabilities on its critical telecom infrastructure and protect customer information.
Telenor is a leading telecommunications company across the Nordics and Asia with more than 188 million customers worldwide. It has mobile operations in the Nordics, including Norway, Sweden, Denmark, Finland and in Asia, including Pakistan, Bangladesh, Thailand, Malaysia, and Myanmar. Connecting customers to what matters most has been the core of its business for more than 160 years.
Telenor’s wholly owned subsidiary, Telenor Sweden, is one of the largest mobile operator in the country and provider of fixed broadband services to the consumer and business markets in Sweden.
Telecom companies maintain and operate critical communications infrastructure. This is used to transmit large amounts of sensitive consumer and business data, due to which cyberattacks against the industry are soaring. Meanwhile, the rapid advancements of new technologies such as the Internet of Things (IoT) and 5G dramatically increase the potential attack surface and threat landscape for a telco.
To protect customer data and the security of its critical infrastructure, Telenor is investing in security capabilities across its organisation as well as with its suppliers and third-party providers. It ensures the same level of control over data and infrastructure, independent of operating – or business model.
One such initiative is crowdsourcing security through a bug bounty program with YesWeHack to identify security gaps and ensure adequate data protection. Crowdsourced security will help Telenor Sweden access a diverse range of security researchers, also called hunters, with unique specialisations and in-depth industry knowledge.
“The partnership with YesWeHack is one of the ways we work with security and maybe one of the most important ones in our proactive work to stop cybercriminals. The return on investment is huge since we get access to thousands of security researchers while only paying a fraction of the cost it would take to recruit them all individually,” said Ulf Andersson, Head of Information Security at Telenor Sweden. “We are now planning to level up both the private and public program to make it even more attractive and generate more reports,” he added.
Telenor Sweden had started with a private bug bounty program where YesWeHack invited selected researchers to hack it’s infrastructure. This was followed by a public bug bounty program where the telco is now being scrutinised by the entire YesWeHack community, representing more than 35,000 global cybersecurity researchers.
“Through the YesWeHack bug bounty program, we are connected to one of the finest global networks of hackers to help us find security gaps in our infrastructure. It's all about finding vulnerabilities before anyone else. By being proactive and allowing the hacking of our infrastructure, we can find weaknesses before the criminals do and fix them,” said Marcus Lundblad, Security Engineer at Telenor Sweden.
By reducing security gaps and ensuring adequate data protection, Telenor Sweden gives its customers the comfort to share information and allow them to reap the benefits of the data-driven economy.
“Protecting people in their digital life with security at the foundation is the core value of Telenor,” said Guillaume Vassault-Houlière, CEO and Co-Founder of YesWeHack. “Telenor Sweden has achieved the position of a trusted and secure provider in all markets because of its focus on customer data protection and by defending its critical infrastructure by adopting game-changing solutions such as bug bounty,” he added.
Cybersecurity experts from Telenor Sweden will share best practices on guarding against cyber threats in a webinar on March 17th 2022. They will also share why the organisation has put bug bounty at the core of its security posture and will detail the clear benefits of a platform-driven, results-oriented and crowdsourced approach to security audits. For more information and registration visit our blog .
ABOUT YESWEHACK
Founded in 2015, YesWeHack is the #1 European Bug Bounty & VDP Platform. YesWeHack offers companies an innovative approach to cybersecurity with Bug Bounty (pay-per-vulnerability discovered), connecting more than 35,000 cybersecurity experts (ethical hackers) across 170 countries with organisations to secure their exposed scopes and reporting vulnerabilities in their websites, mobile apps, infrastructure and connected devices. YesWeHack runs private and public programs for hundreds of organisations worldwide in compliance with the strictest European regulations.
In addition to the Bug Bounty platform, YesWeHack also offers support in creating a Vulnerability Disclosure Policy (VDP), a learning platform for ethical hackers called Dojo and a training platform for educational institutions, YesWeHackEDU. For more information: www.yeswehack.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005007/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom